Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 32, pages 439–442 (2003)Cite this article

Summary:

A 67-year-old man with AML, who had a 21-year history of psoriasis without remission, received a reduced-intensity transplantation from an HLA-identical sibling. The preparative regimen consisted of busulfan and fludarabine. Graft-versus-host-disease (GVHD) prophylaxis was cyclosporine and methotrexate. Psoriasis was completely resolved on day 18. The subsequent clinical course was uneventful until day 42, when psoriasis recurred at the same sites as before RIST. Peripheral blood examined on day 63 showed mixed chimerism with 54% recipient type. Cyclosporine was rapidly tapered off over the next 2 weeks. On day 90, 100% donor-type chimerism was confirmed. Subsequently, psoriasis improved simultaneously with the occurrence of mucositis and rash as a manifestation of GVHD. Scattered erythematous patches of psoriasis disappeared again by day 105. We initiated 0.5 mg/kg prednisolone on day 119, and resumed cyclosporine on day 133. At 7 months after RIST, he still suffers from chronic GVHD, but his psoriasis remains in remission for the first time in 21 years. The anti-psoriasis effect of the conditioning is mild and transient, while the graft-versus-autoimmunity effect, related to the induction of complete donor-type chimerism and GVHD, is more profound and persisting. A graft-versus-autoimmunity effect lies in the delicate balance between alloimmunity and immunosuppressant used for GVHD prophylaxis/treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Binks M, Passweg JR, Furst D et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 2001; 60: 577–584.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Burt RK, Slavin S, Burns WH, Marmont AM . Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 99: 768–784.

    Article  CAS  PubMed  Google Scholar 

  3. Burt RK, Slavin S, Burns WH, Marmont AM . Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Int J Hematol 2002; 76 (Suppl 1): 226–247.

    Article  PubMed  Google Scholar 

  4. Snowden JA, Biggs JC, Milliken ST et al. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthr Rheum 1999; 42: 2286–2292.

    Article  CAS  Google Scholar 

  5. Marmont AM . Immunoablation followed or not by hematopoietic stem cells as an intense therapy for severe autoimmune diseases (SADS). New perspectives, new problems. Haematologica 2000; 85 (Suppl): 71–80.

    CAS  PubMed  Google Scholar 

  6. Marmont AM . Immunoablation followed or not by hematopoietic stem cells as an intense therapy for severe autoimmune diseases. New perspectives, new problems. Haematologica 2001; 86: 337–345.

    CAS  PubMed  Google Scholar 

  7. Slavin S, Nagler A, Varadi G, Or R . Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–857.

    Article  CAS  PubMed  Google Scholar 

  8. Saito T, Kanda Y, Kami M et al. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. Clin Cancer Res 2002; 8: 1014–1020.

    CAS  PubMed  Google Scholar 

  9. Fredriksson T, Pettersson U . Severe psoriasis–oral therapy with a new retinoid. Dermatologica 1978; 157: 238–244.

    Article  CAS  PubMed  Google Scholar 

  10. Chakrabarti S, Handa SK, Bryon RJ et al. Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant? Transplantation 2001; 72: 340–342.

    Article  CAS  PubMed  Google Scholar 

  11. Adkins DR, Abidi MH, Brown RA et al. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy. Bone Marrow Transplant 2000; 26: 1239–1241.

    Article  CAS  PubMed  Google Scholar 

  12. Spitzer TR, Sykes M . Treatment of renal-cell cancer by transplantation of allogeneic stem cells. N Engl J Med 2001; 344: 137–138.

    Article  CAS  PubMed  Google Scholar 

  13. Khouri IF, Saliba RM, Giralt SA et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. Blood 2001; 98: 3595–3599.

    Article  CAS  PubMed  Google Scholar 

  14. Giralt S, Aleman A, Anagnostopoulos A et al. Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma. Bone Marrow Transplant 2002; 30: 367–373.

    Article  CAS  PubMed  Google Scholar 

  15. Michallet M, Bilger K, Garban F et al. Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pre transplantation and post transplantation factors on outcome. J Clin Oncol 2001; 19: 3340–3349.

    Article  CAS  PubMed  Google Scholar 

  16. Davidson A, Diamond B . Autoimmune diseases. N Engl J Med 2001; 345: 340–350.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematopoietic Stem Cell Transplant Unit, National Cancer Center Hospital, Tokyo, Japan

    R Kojima, M Kami, S-W Kim, N Murashige, Y Kishi, A Hori, O Imataki, T Hamaki, M Sakiyama, A Makimoto, Y Heike, R Tanosaki & Y Takaue

  2. Department of Dermatology, National Cancer Center Hospital, Tokyo, Japan

    Y Fujisawa

  3. Department of Hematology, JR Tokyo General Hospital, Japan

    S Masuo

Authors
  1. R Kojima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Kami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S-W Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Murashige
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Kishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Hori
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O Imataki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Hamaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Sakiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S Masuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Y Fujisawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A Makimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Y Heike
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. R Tanosaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Y Takaue
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kojima, R., Kami, M., Kim, SW. et al. Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 32, 439–442 (2003). https://doi.org/10.1038/sj.bmt.1704146

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704146

Keywords

This article is cited by

Search

Advanced search

Quick links